Schroder Investment Management Group
MIRM icon

Schroder Investment Management Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Schroder Investment Management Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
+20,759
New +$2.08M ﹤0.01% 879
2024
Q2 		– Sell
-67,500
Closed -$1.7M – 1240
2024
Q1 		$1.7M Hold
67,500
– – ﹤0.01% 945
2023
Q4 		$1.99M Buy
+67,500
New +$2.04M ﹤0.01% 911

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schroder Investment Management Group's MIRM Position: Q2 2026 in Review

Schroder Investment Management Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 20,759 shares worth $2.55M. The stake represents ﹤0.01% of the portfolio and ranks #879 among its holdings. This is a return to the name: Schroder Investment Management Group previously reported a position in MIRM as recently as Q1 2024.

Schroder Investment Management Group first reported a position in MIRM in Q4 2023 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Schroder Investment Management Group held 20,759 shares of Mirum Pharmaceuticals worth $2.55M as of Q2 2026.
  • Mirum Pharmaceuticals was a new Schroder Investment Management Group position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #879 holding.
  • Schroder Investment Management Group first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.